Loss of Response and Frequency of Adverse Events in Patients with Ulcerative Colitis and Crohn’s Disease when Switching from the Original Infliximab to Its Biosimilars
Terapevtičeskij arhiv（2021）
关键词
biosimilar,Crohn's disease,inflammatory bowel disease,infliximab,ulcerative colitis
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要